Ultralife Stock Performance
| ULBI Stock | USD 5.58 0.17 2.96% |
The entity has a beta of 1.3, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Ultralife will likely underperform. At this point, Ultralife has a negative expected return of -0.42%. Please make sure to validate Ultralife's maximum drawdown, accumulation distribution, as well as the relationship between the Accumulation Distribution and day typical price , to decide if Ultralife performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Ultralife has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental drivers remain fairly strong which may send shares a bit higher in April 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders. ...more
Actual Historical Performance (%)
One Day Return (2.96) | Five Day Return (0.71) | Year To Date Return (24.49) | Ten Year Return 50 | All Time Return (57.89) |
1 | Investors in Ultralife have seen returns of 21 percent over the past three years | 12/23/2024 |
2 | Acquisition by Whitmore Bradford T of 16400 shares of Ultralife at 4.5986 subject to Rule 16b-3 | 12/27/2024 |
3 | Acquisition by Michael Manna of 200 shares of Ultralife at 3.91 subject to Rule 16b-3 | 01/03/2025 |
4 | Ultralife Corporation Expands Leadership Team to Drive Rapid Growth Plans | 01/06/2025 |
5 | Acquisition by Philip Fain of 7179 shares of Ultralife at 5.7075 subject to Rule 16b-3 | 01/14/2025 |
6 | Ultralife Corporation A High-Risk Stock With Just Enough Upside To Hold - Seeking Alpha | 01/22/2025 |
7 | Acquisition by Whitmore Bradford T of 5113 shares of Ultralife at 7.9509 subject to Rule 16b-3 | 01/24/2025 |
8 | Ultralife Expected to Announce Quarterly Earnings on Thursday | 02/19/2025 |
9 | IFP Advisors Inc Makes New Investment in Ultralife Co. - Defense World | 03/06/2025 |
| Begin Period Cash Flow | 5.7 M |
Ultralife |
Ultralife Relative Risk vs. Return Landscape
If you would invest 728.00 in Ultralife on December 19, 2024 and sell it today you would lose (170.00) from holding Ultralife or give up 23.35% of portfolio value over 90 days. Ultralife is currently does not generate positive expected returns and assumes 2.5896% risk (volatility on return distribution) over the 90 days horizon. In different words, 23% of stocks are less volatile than Ultralife, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Ultralife Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ultralife's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Ultralife, and traders can use it to determine the average amount a Ultralife's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1609
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ULBI |
Estimated Market Risk
| 2.59 actual daily | 23 77% of assets are more volatile |
Expected Return
| -0.42 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.16 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Ultralife is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ultralife by adding Ultralife to a well-diversified portfolio.
Ultralife Fundamentals Growth
Ultralife Stock prices reflect investors' perceptions of the future prospects and financial health of Ultralife, and Ultralife fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ultralife Stock performance.
| Return On Equity | 0.0704 | ||||
| Return On Asset | 0.0435 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 92.81 M | ||||
| Shares Outstanding | 16.62 M | ||||
| Price To Earning | 13.93 X | ||||
| Price To Book | 0.68 X | ||||
| Price To Sales | 0.58 X | ||||
| Revenue | 158.64 M | ||||
| Gross Profit | 29.4 M | ||||
| EBITDA | 15.04 M | ||||
| Net Income | 7.2 M | ||||
| Cash And Equivalents | 5.11 M | ||||
| Cash Per Share | 0.32 X | ||||
| Total Debt | 29.16 M | ||||
| Debt To Equity | 0.20 % | ||||
| Current Ratio | 3.24 X | ||||
| Book Value Per Share | 8.09 X | ||||
| Cash Flow From Operations | 1.93 M | ||||
| Earnings Per Share | 0.58 X | ||||
| Market Capitalization | 132.82 M | ||||
| Total Asset | 178.28 M | ||||
| Retained Earnings | (40.75 M) | ||||
| Working Capital | 66.47 M | ||||
| Current Asset | 51.95 M | ||||
| Current Liabilities | 10.85 M | ||||
About Ultralife Performance
By evaluating Ultralife's fundamental ratios, stakeholders can gain valuable insights into Ultralife's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Ultralife has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Ultralife has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 116.10 | 102.68 | |
| Return On Tangible Assets | 0.05 | 0.05 | |
| Return On Capital Employed | 0.06 | 0.06 | |
| Return On Assets | 0.04 | 0.04 | |
| Return On Equity | 0.05 | 0.05 |
Things to note about Ultralife performance evaluation
Checking the ongoing alerts about Ultralife for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Ultralife help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Ultralife generated a negative expected return over the last 90 days | |
| Ultralife is unlikely to experience financial distress in the next 2 years | |
| About 75.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from news.google.com: IFP Advisors Inc Makes New Investment in Ultralife Co. - Defense World |
- Analyzing Ultralife's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ultralife's stock is overvalued or undervalued compared to its peers.
- Examining Ultralife's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Ultralife's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ultralife's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Ultralife's stock. These opinions can provide insight into Ultralife's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Ultralife Stock analysis
When running Ultralife's price analysis, check to measure Ultralife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ultralife is operating at the current time. Most of Ultralife's value examination focuses on studying past and present price action to predict the probability of Ultralife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ultralife's price. Additionally, you may evaluate how the addition of Ultralife to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |